Type 2 Diabetes: Cardiovascular and Related Complications and Evidence-Based Complementary Treatments (CHES)
This course is only for CHES practitioners.
Diabetes medications can lower glucose, but they do not reduce inflammation! Annually, 29 million Americans are diagnosed with T2D; only 36% achieve good medical outcomes. Learn complementary interventions to help control complications: CV, kidney, vision, and peripheral nerve problems. “Chronic high levels of blood sugar are actually due to excessive generation of unopposed free radicals and reactive oxygen species, which eventually jeopardize the formation of the protective molecule nitric oxide,” thus reducing oxygen supply to the body.
Quotes:
Supported my belief how important diet and exercise can be. I enjoyed the book. JC 4/2020
Liked most: The focus on alternative approaches/treatments. Very in-depth material. MM 1/2021
I got an incredible amount of information out of this course. CK 3/2021
Choose between two options:
CHES Program ID # SS114228_T2D15 Max CHES 15 hours / Advanced MCHES 5 hours
CHES Program ID # SS114228_T2D35 Max CHES 35 hours / Advanced MCHES 8 hours
Book Details
Course Objectives
1.2.1 Identify sources of secondary data related to health
1.2.3 review related literature
1.4.2 Identify and analyze factors that impact health
1.2.6 Determine the validity of existing data
4.3.4 Identify usable items from existing instruments
4.1.6 Determine Types of data to be collected
4.3.1 Identify existing data collection instruments
1.1.4 Apply theories or models to the assessment process
2.3.3 Apply principles of evidence-based practice in selecting or designing strategies/interventions
4.6.8 Develop recommendations based on findings
Recommended For...
Why we chose this book
The main author of this book, Dr. Robert Fried, is highly qualified as a researcher, medical school instructor, and international speaker and consultant. His book covers evidence-based research into complementary treatments. The book is readable, interesting, and detailed in the physiology of this disease process.
About the author
Dr. Robert Fried was Professor Emeritus at Cornell University Medical School, and had appointments at Temple University Medical School, and he was a research scientist at the Aviation Medical Acceleration Laboratory (Project Mercury) among many other positions. He authored more than 45 scientific publications in peer-reviewed journals, and he holds patents in biomedical instrumentation.